"Adenoviridae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases.
| Descriptor ID |
D000256
|
| MeSH Number(s) |
B04.280.030
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenoviridae".
Below are MeSH descriptors whose meaning is more specific than "Adenoviridae".
This graph shows the total number of publications written about "Adenoviridae" by people in this website by year, and whether "Adenoviridae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 2 | 0 | 2 |
| 1996 | 2 | 2 | 4 |
| 1997 | 2 | 8 | 10 |
| 1998 | 4 | 2 | 6 |
| 1999 | 1 | 6 | 7 |
| 2000 | 3 | 4 | 7 |
| 2001 | 4 | 8 | 12 |
| 2002 | 6 | 12 | 18 |
| 2003 | 2 | 24 | 26 |
| 2004 | 4 | 18 | 22 |
| 2005 | 3 | 11 | 14 |
| 2006 | 5 | 9 | 14 |
| 2007 | 7 | 8 | 15 |
| 2008 | 3 | 9 | 12 |
| 2009 | 5 | 3 | 8 |
| 2010 | 1 | 6 | 7 |
| 2011 | 3 | 5 | 8 |
| 2012 | 1 | 2 | 3 |
| 2013 | 4 | 4 | 8 |
| 2014 | 3 | 4 | 7 |
| 2015 | 0 | 2 | 2 |
| 2016 | 3 | 2 | 5 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenoviridae" by people in Profiles.
-
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFß signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer Gene Ther. 2024 Apr; 31(4):574-585.
-
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes. Leuk Lymphoma. 2022 02; 63(2):435-442.
-
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ß Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models. Hum Gene Ther. 2020 08; 31(15-16):863-880.
-
Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma. Reprod Sci. 2020 02; 27(2):644-654.
-
An Oncolytic Adenovirus Targeting Transforming Growth Factor ß Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy. Hum Gene Ther. 2019 09; 30(9):1117-1132.
-
Inhibition of upper small intestinal mTOR lowers plasma glucose levels by inhibiting glucose production. Nat Commun. 2019 02 12; 10(1):714.
-
Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liver. Diagn Microbiol Infect Dis. 2019 Jun; 94(2):180-182.
-
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics. 2018 10; 15(4):1127-1138.
-
[Twist regulates proliferation, migration and invasion of osteosarcoma cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao. 2018 May 20; 38(5):554-560.
-
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. Urol Oncol. 2018 10; 36(10):440-447.